Hongli Pharma: Zinc Stearate Conversion to "A" of Huzhou Prospect Pharmaceutical Co., Ltd. Approved for Listing

People’s Financial News, March 13 — According to Hongri Pharmaceutical, recently, the medicinal excipient zinc stearate from Huzhou Zhanwang Pharmaceutical Co., Ltd., a subsidiary of Hongri Pharmaceutical, has been reclassified from “I” to “A” after review by the Drug Evaluation Center of the National Medical Products Administration. Zinc stearate is mainly used as a lubricant in solid dosage forms. Its hydrophobic properties can effectively prevent tablets from absorbing moisture, ensuring the stability and quality of the formulation.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin